Product
Currency:CNY
2024/H1
Stock NameRevenueRatio
Pharmaceutical R & D and consistency Evaluation94.42M48.10%
clinical trials82.61M42.08%
Leasing and property Services Business14.25M7.26%
Other income3.13M1.59%
Other business1.89M0.96%
Industry
Currency:CNY
2023/FY
Stock NameRevenueRatio
Pharmaceutical industry338.57M91.68%
租赁及物业服务行业27.65M7.49%
Other3.06M0.83%
Region
Currency:CNY
2023/FY
Stock NameRevenueRatio
Domestic sales366.22M99.17%
Other business3.06M0.83%